Johnson & Johnson Aktie

131,06EUR 3,86EUR 3,03%
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Aktionärsstruktur

Inhaber in %
Freefloat 99,86
The Vanguard Group, Inc. 8,66
Vanguard Group, Inc. (Subfiler) 8,22
State Street Corp. 5,47
Vanguard Total Stock Market Index Fund 2,83
BlackRock Institutional Trust Co. NA 2,35
BlackRock Fund Advisors 2,35
Vanguard 500 Index Fund 2,01
Geode Capital Management LLC 1,52
Wellington Management Co. LLP 1,35
State Farm Investment Management Corp. 1,31
Northern Trust Corp. 1,24
Massachusetts Financial Services Co. 1,07
Norges Bank (13F) 1,05
Government Pension Fund - Global (The) 1,03

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2016 2017 2018 2019 2020
Personal am Ende des Jahres 126 400 134 000 135 100 132 200 134 500
Umsatz pro Mitarbeiter in Mio. EUR 0,57 0,57 0,60 0,62 0,61

Bilanz (in Mio. EUR) - Aktiva

2016 2017 2018 2019 2020
Summe Umlaufvermögen 65 032 43 088 46 033 45 274 51 237
Summe Anlagevermögen 97 544 94 741 90 232 88 152 99 644
Summe Aktiva 141 208 157 303 152 954 157 728 174 894

Bilanz (in Mio. EUR) - Passiva

2016 2017 2018 2019 2020
Gesamtverschuldung/ -verbindlichkeiten 27 126 34 581 30 480 28 681 36 366
Summe Fremdkapital 70 790 97 143 93 202 98 257 111 616
Summe Eigenkapital 70 418 60 160 59 752 59 471 63 278
Summe Passiva 141 208 157 303 152 954 157 728 174 894

Adresse

One Johnson & Johnson Plaza, 08933 New Brunswick
Telefon +1 (732) 524-0400
Internet http://www.jnj.com

Management

A. Eugene Washington
Independent Director
Alex Gorsky
Chairman & Chief Executive Officer
Anne M. Mulcahy
Lead Independent Director
Ashley A. McEvoy
Executive VP & Worldwide Chairman-Medical Devices
Charles O. Prince
Independent Director
Chris DelOrefice
Vice President-Investor Relations
Ciro Römer
Company Group Chairman
D. Scott Davis
Independent Director
Euan Stuart Thomson
Global Head-Digital Technology
Frederic H. Moll
Chief Development Officer
Hubert Joly
Independent Director
Ian Edward Lamert Davis
Independent Director
James D. Swanson
Global Chief Information Officer & Executive VP
Jennifer A. Doudna
Independent Director
Jennifer Taubert
EVP & Worldwide Chairman-Pharmaceuticals
Joaquin Duato
Vice Chairman-Executive Committee
Joseph J. Wolk
Chief Financial Officer & Executive Vice President
Kathleen M. Widmer
Chairman-Consumer North America
Lisa Romanko
Senior Director-Investor Relations
Marillyn A. Hewson
Independent Director
Mark Alan Weinberger
Independent Director
Mark B. McClellan
Independent Director
Mary C. Beckerle
Independent Director
Mathai Mammen
Head-Science & Development
Matthew Orlando
Secretary
Matthew Stuckley
Senior Finance Director
Michael E. Sneed
Chief Communication Officer & Executive VP
Michael H. Ullmann
Executive Vice President & General Counsel
Nadja Y. West
Director
Paulus Stoffels
Chief Scientific Officer
Peter M. Fasolo
Chief Human Resources Officer & Executive VP
Peter Shen
Global Head-Research & Development
Robert J. Decker
Chief Accounting Officer & Controller
Ronald A. Kapusta
Chief Accounting Officer & Controller
Ronald A. Williams
Independent Director
Sarah L. Colamarino
Vice President-Corporate Equity
Scott White
Company Group Chairman
Thomas J. Spellman
Secretary